Clinical Trial Update: Safety and Efficacy Study of Oral Zabofloxacin in Community Acquired Pneumonia [Phase 2]

View source ↗

Summary

A Phase 2 safety and efficacy study of oral zabofloxacin for community-acquired pneumonia has been terminated, according to the trial update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• Zabofloxacin (zabofloxacin)

Snippet

Sponsor: IASO Pharma Inc. | Conditions: Community Acquired Pneumonia | Phase 2 | Status: TERMINATED